Scientific articles published by members of ReMicS network
Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency.
Effects of dietary intervention and n-3 PUFA supplementation on markers of gut-related inflammation and their association with cardiovascular events in a high-risk population.
Circulating markers of gut barrier function associated with disease severity in primary sclerosing cholangitis.
Autoimmunity and Inflammation in CVID: a Possible Crosstalk between Immune Activation, Gut Microbiota, and Epigenetic Modifications.
TaME-seq: An efficient sequencing approach for characterisation of HPV genomic variability and chromosomal integration.
Gut microbiota composition during a 12-week intervention with delayed-release dimethyl fumarate in multiple sclerosis - a pilot trial.